Qube Research & Technologies Ltd
- SEC CIK
- 0001729829
- Latest filing
- Aug 14, 2026
VRCA holding history
Verrica Pharmaceuticals Inc. in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRCA overviewAll 13F holders of VRCAFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −5,296−100.0% | Sold outConverted for a 1-for-10 split | Holders |
| Q2 2025 | 52,955 | $28.1K | <0.1% | +52,955 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −35,262−100.0% | Sold out | Holders |
| Q4 2024 | 35,262 | $24.7K | <0.1% | −286,924−89.1% | Reduced | Holders |
| Q3 2024 | 322,186 | $467.2K | <0.1% | +322,186 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −54,087−100.0% | Sold out | Holders |
| Q1 2023 | 54,087 | $351.6K | <0.1% | +54,087 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −11,024−100.0% | Sold out | Holders |
| Q3 2022 | 11,024 | $32.0K | <0.1% | −329−2.9% | Reduced | Holders |
| Q2 2022 | 11,353 | $22.0K | <0.1% | +11,353 | New | Holders |